Comparison of MRI/US Fusion Targeted Biopsy and Systematic Biopsy in Biopsy-Naïve Prostate Patients with Elevated Prostate-Specific Antigen: A Diagnostic Study-Reference-Cited by-同舟云学术

Comparison of MRI/US Fusion Targeted Biopsy and Systematic Biopsy in Biopsy-Naïve Prostate Patients with Elevated Prostate-Specific Antigen: A Diagnostic Study

Published:2022-04 Issue: Volume:Volume 14 Page:1395-1407
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Huang Chen,Huang Yuhua,Pu Jinxian,Xi Qilin,Wei Xuedong,Qiu Feng,Wang Ximing,Zhao Xiaojun,Guo Linchuan,Hou Jianquan

Publisher

Informa UK Limited

Subject

Oncology

Reference22 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Urologic cancer in China

3. Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting

4. Contemporary Trends in Low Risk Prostate Cancer: Risk Assessment and Treatment

5. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate Cancer Lesions in Transition Zone Exhibit a Higher Propensity for Pathological Upgrading in Radical Prostatectomy;2024-08-18

2. Clinical risk prediction model and external validation of positive surgical margin in laparoscopic radical prostatectomy based on MRI lesion location;Clinical and Translational Oncology;2024-03-13

3. Cost-effectiveness analysis of different anesthesia strategies for transperineal MRI/US fusion prostate biopsy;Asian Journal of Andrology;2024-02-20

4. Triglyceride-glucose index is a predictor of the risk of prostate cancer: a retrospective study based on a transprostatic aspiration biopsy population;Frontiers in Endocrinology;2024-01-08

5. Clinical and Radiological Factors for Predicting Clinically Significant Prostate Cancer in Biopsy-Naive Patients With PI-RADS 3 Lesions;Technology in Cancer Research & Treatment;2024-01